The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 2, 1999, Pages 635-642

  Mellon, R Daniel ^a   Bayer, Barbara M ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIBATIDINE; MORPHINE; NICOTINE; NICOTINIC RECEPTOR; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; DRUG ABUSE; DRUG EFFECT; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MALE; NEUROENDOCRINE SYSTEM; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ADJUVANTS, IMMUNOLOGIC; ANALGESICS, OPIOID; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; CHLORISONDAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LYMPHOCYTE ACTIVATION; MALE; MORPHINE; NALTREXONE; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PITUITARY-ADRENAL SYSTEM; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; RECEPTORS, OPIOID; T-LYMPHOCYTES;

EID: 0032987805     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Badio B and Daly JW (1994) Epibatidine, a potent analgesic and nicotinic agonist. Mol Pharmacol 45:563-569.
2. Bayer BM, Gastonguay MR and Hernandez MC (1992) Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility. Immunopharmacology 23:117-124.
3. Bayer BM, Hernandez M and Irvin L (3990) Suppression of lymphocyte activity after acute morphine administration appears to be glucocorticoid independent, in Alcohol, Immunomodulation, and AIDS (Pawloski A, Seminara D and Watson R eds) pp 273-282, Alan R. Liss, Inc., New York.
4. Britton DR and Indyk E (1989) Effects of ganglionic blocking agents on behavioral responses to centrally administered CRF. Brain Res 478:205-210.
5. Caggiula AR, Epstein LH, Perkins KA and Saylor S (1995) Different methods of assessing nicotine-induced antinociception may engage different neural mechanisms. Psychopharmacology 122:301-306.
6. Caggiula AR, McAllister CG, Epstein LH, Antelman SM, Knopf S, Saylor S and Perkins KA (1992) Nicotine suppresses the proliferative response of peripheral blood lymphocytes in rats. Drug Dev Res 26:473-479.
7. Cam GR, Bassett JR and Cairncross KD (1979) The actions of nicotine on the pituitary-adrenal cortical axis. Arch Int Pharmacodyn Ther 237:49-66.
8. Clarke PBS (1984) Chronic central nicotinic blockade after a single administration of the bisquarternary ganglionic-blocking drug chlorisondamine. Br J Pharmacol 83:527-535.
9. Clarke PBS, Chaudieu I, El-Bizri H, Boksa P, Quik M, Esplin BA and Capek R (1994) The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion. Br J Pharmacol 111:397-405.
10. D'Amour FE and Smith DL (1941) A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74-79.
11. Dimitrova SS, Felten SY and Felten DL (1995) Sympathetic noradrenergic innervation of spleen, thymus and mesenteric lymph nodes (MLN): A comparison between Sprague-Dawley, Lewis and Fischer 344 rats. Soc Neurosci Abstr 21:2071.
12. Fecho K, Maslonek KA, Dykstra LA and Lysle DT (1993) Alterations of immune status induced by the sympathetic nervous system: Immunomodulatory effects of DMPP alone and in combination with morphine. Brain Behav Immun 7:253-270.
13. Flores CM, DeCamp RM, Kilo S, Rogers SW and Hargreaves KM (1996) Neuronal nicotinic receptor expression in sensory neurons of the rat trigeminal ganglion: Demonstration of a3β4, a novel subtype in the mammalian nervous system. J Neurosci 16:7892-7901.
14. Flores CM, Hernandez MC, Hargreaves KM and Bayer BM (1990) Restraint stress-induced elevations in plasma corticosterone and β-endorphin are not accompanied by alterations in immune function. J Neuroimmunol 28:219-225.
15. Flores LR, Dretchen KL and Bayer BM (1996) Potential role of the autonomic nervous system in the immunosuppressive effects of acute morphine administration. Eur J Pharm 318:437-446.
16. Hernandez MC, Flores LR and Bayer BM (1993) Immunosuppression by morphine is mediated by central pathways. J Pharmacol Exp Ther 267:1336-1341.
17. 3H]Epibatidine binding to nicotinic cholinergic receptors in brain. Med Chem Res 4:538-546.
18. 3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Mol Pharmacol 48:280-287.
19. Irwin M, Hauger RL, Brown M and Britton KT (1988) CRF activates autonomic nervous system and reduces natural killer cytotoxicity. Am J Physiol 24:R744-R747.
20. Keller SE, Schleifer SJ, Liotta AS, Bond RN, Farhoody N and Stein M (1988) Stress-induced alterations of immunity in hypophysectomized rats. Proc Natl Acad Sci USA 85:9297-9301
21. Keller SE, Weiss JM, Miller NE and Stein M (1983) Stress-induced suppression of immunity in adrenalectomized rats. Science (Wash DC) 221:1301-1304.
22. Konno S, Chiao JW and Wu JM (1986) Effects of nicotine on cellular proliferation, cell cycle phase distribution, and macromolecular synthesis in human promyelocytic HL-60 leukemia cells. Cancer Lett 33:91-97.
23. Madden KS and Felten DL (1995) Experimental basis for neural-immune interactions. Physiol Rev 75:77-106.
24. Maslinski W, Grabczewska E and Ryzewski J (1980) Acetylcholine receptors of rat lymphocytes. Biochim Biophys Acta 633:269-273.
25. Matta SG, Beyer HS, McAllen KM and Sharp BM (1987) Nicotine elevates rat plasma ACTH by a central mechanism. J Pharmacol Exp Ther 243:217-226
26. McAllister CG, Caggiula AR, Knopf S, Epstein LH, Miller AL, Antelman SM and Perkins KA (1994) Immunological effects of acute and chronic nicotine administration in rats. J Neuroimmunol 50:43-49.
27. Mellon RD and Bayer BM (1998a) Evidence for central opioid receptors in the immunomodulatory effects of morphine: Review of potential mechanism(s) of action. J Neuroimmunol 83:19-28.
28. Mellon RD and Bayer BM (1998b) Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity. Brain Res 789: 56-67.
29. Mellon RD, Hernandez MC, Flores LR, Kellar KJ and Bayer BM (1996) Immunosuppression by morphine, nicotine, and epibatidine: Autonomic nervous system involvement. (Abstract) FASEB J 10:129.
30. Menard L and Rola-Pleszczynski M (1987) Nicotine induces T-suppressor cells: Modulation by the nicotinic antagonist D-turbocurarine and myasthenic serum. Clin Immunol Immunopathol 44:107-113.
31. Nikolarakis KE, Pfeiffer A, Stalla GK and Herz A (1989) Faciliation of ACTH secretion by morphine is mediated by activation of CRF releasing neurons and sympathetic neuronal pathways. Brain Res 498:385-388.
32. Parrillo JE and Fauci AS (1979) Mechanisms of glucocorticoid action on immune processes. Annu Rev Pharmacol Toxicol 19:179-201.
33. Paxinos G and Watson C (1997) The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego.
34. Qian C, Li T, Shen TY, Libertine-Garahan L, Eckman J, Biftu T and Ip S (1993) Epibatidine is a nicotinic analgesic. Eur J Pharm 250:R13-R14.
35. Richman DP and Arnason BGW (1979) Nicotinic acetylcholine receptor: Evidence for a functionally distinct receptor on human lymphocytes. Proc Natl Acad Sci USA 76:4632-4635.
36. Saito M, Akiyoshi M and Shimizu Y (1991) Possible role of the sympathetic nervous system in responses to interleukin-1. Brain Res Bull 27:305-308.
37. Spande TF, Garraffo HM, Edwards MW, Yeh HJC, Pannell L and Daly JW (1992) Epibatidine: A novel (chloropyridyl)axabicycloheptane with potent analgesic activity from an Ecuadoran poison frog. J Am Chem Soc 114:3475-3478.
38. Toyabe S, Iiai T, Fukuda M, Kawamura T, Suzuki S, Uchiyama M and Abo T (1997) Identification of nicotinic acetylcholine receptors on lymphocytes in the periphery as well as thymus in mice. Immunology 92:201-205.
39. Tripathi HL, Martin BR and Aceto MD (1982) Nicotine-induced antinociception in rats and mice: Correlation with nicotinic brain levels. J Pharmacol Exp Ther 221:91-96.